K-ras activation generates an inflammatory response in lung tumors-Reference-Cited by-同舟云学术

K-ras activation generates an inflammatory response in lung tumors

Published:2005-11-14 Issue:14 Volume:25 Page:2105-2112
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Ji H,Houghton A M,Mariani T J,Perera S,Kim C B,Padera R,Tonon G,McNamara K,Marconcini L A,Hezel A,El-Bardeesy N,Bronson R T,Sugarbaker D,Maser R S,Shapiro S D,Wong K-K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1209237.pdf

Reference34 articles.

1. Adjei A . (2001). J Natl Cancer Inst 93: 1062–1074.

2. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY et al. (1998). J Clin Invest 102: 465–472.

3. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter R . (1996). J Clin Invest 97: 2792–2802.

4. Baggiolini M, Loetscher P, Moser B . (1995). Int J Immunopharmacol 17: 103–108.

5. Baggiolini M, Moser B, Clark-Lewis I . (1994). Chest 105: 95S–98S.

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?;Lung Cancer;2024-08

3. CXCR1/2 antagonism inhibits neutrophil function and not recruitment in cancer;OncoImmunology;2024-07-26

4. Cytosolic DNA sensor AIM2 promotes KRAS‐driven lung cancer independent of inflammasomes;Cancer Science;2024-04-09

5. Exploiting the therapeutic implications of KRAS inhibition on tumor immunity;Cancer Cell;2024-03